Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population
Sponsor: Benaroya Research Institute
Summary
To assess the effectiveness of Amisulpride to treat Post Operative Nausea and Vomiting (PONV) and to assess the effectiveness of Amisulpride to prevent PONV following bariatric surgery.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-09-13
Completion Date
2026-01
Last Updated
2024-09-26
Healthy Volunteers
Yes
Conditions
Interventions
Amisulpride IV Prevention
Patients in this arm will receive Amisulpride 5mg IV as a preventative dose after the induction of anesthesia
Amisulpride IV Treatment
Patients in this arm will receive Amisulpride 10mg IV for first-line treatment of Post-Operative Nausea and Vomiting in the post-anesthesia care unit.
Placebo Preventative
Patients in this arm will receive placebo (Normal Saline) while under general anesthesia
Placebo Treatment
Patients in this Arm will receive placebo as first line treatment of Post-Operative Nausea and Vomiting in the Post Anesthesia Care Unit
Locations (1)
Virginia Mason Medical Center
Seattle, Washington, United States